The Centre for Eye Research Australia | ClinicalTrials HQ

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Defining Retinal Structures Using Hyperspectral Retinal Imaging	Diabetes Complications, age-related macular degeneration, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, glaucoma, macular degeneration, ocular hypertension, retinal degeneration, retinal disorder, vascular disorder	Recruiting	Not applicable	2026-04-29		NCT07555574
Retinal Hyperspectral Imaging in Neurodegenerative Diseases	Alzheimer disease, Arterial Occlusive Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Frontotemporal Lobar Degeneration, Hemic and Lymphatic Diseases, Leukoencephalopathies, Lewy body dementia, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Niemann-Pick disease, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, arteriosclerosis disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, frontotemporal dementia, hereditary disease, histiocytosis, inborn errors of metabolism, intracranial arterial disease, intracranial arteriosclerosis, lymphatic system disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, non-Langerhans cell histiocytosis, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, sphingolipidosis, synucleinopathy, tauopathy, vascular dementia, vascular disorder	Recruiting	Not applicable	2026-04-22		NCT07545473